Docking algorithms for computer-aided drug discovery and design often ignore or restrain the flexibility of the receptor,
which may lead to a loss of accuracy of the relative free enthalpies of binding. In order to evaluate the contribution of
receptor flexibility to relative binding free enthalpies, two host–guest systems have been examined: inclusion complexes of
α-cyclodextrin (αCD) with 1-chlorobenzene (ClBn), 1-bromobenzene (BrBn) and toluene (MeBn), and complexes of DNA with the
minor-groove binding ligands netropsin (Net) and distamycin (Dist). Molecular dynamics simulations and free energy calculations
reveal that restraining of the flexibility of the receptor can have a significant influence on the estimated relative ligand–receptor
binding affinities as well as on the predicted structures of the biomolecular complexes. The influence is particularly pronounced
in the case of flexible receptors such as DNA, where a 50% contribution of DNA flexibility towards the relative ligand–DNA
binding affinities is observed. The differences in the free enthalpy of binding do not arise only from the changes in ligand–DNA
interactions but also from changes in ligand–solvent interactions as well as from the loss of DNA configurational entropy
upon restraining.
Keywords α-Cyclodextrin – Conformational flexibility – Drug design – DNA–ligand binding – Molecular dynamics